Ask Your Colleagues About:

Treatment Strategies
 

New drug with the greatest impact

Posted: Mar 29, 2003

QUESTION:

Hi David:

Great article on new therapies! I couldn't tell which drug you thought will have the most impact on HIV treatment. Can you clarify.

Thanks!


  

RESPONSE FROM:   

    Good question.

    Some of the 'new' drugs presented at the conference are not all that new in that many clinicians already have some experience with these or like agents. On the other end of the spectrum are compounds that are 'way out there' and look great but are in the very early stages of what can be a tortuous road to the pharmacy shelf.

    I am personally upbeat about a number of new therapies. I think a combination tablet of tenofovir/FTC will be very popular. Likewise, the new formulation of amprenavir ("908") will breath new life into this drug.

    For salvage, T-20 and T-1249 are going to have a great impact, IF enough of these medications are able to be made available and affordable to those who need them most.

    I am cautious about predicting the future of the more novel therapies, as exciting as they are, until we get more safety and efficacy data.

    Thanks

    DW




Terms of Use: Please remember that this forum is designed for educational purposes only, and experts are not engaged through this forum in rendering legal or medical advice or professional services. Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Questions and messages posted to this forum are not statements of advice, opinion, or information of The Body PRO, Body Health Resources Corporation or any sponsor of this forum.

Visitors submitting questions remain solely responsible for the content of their messages. Information provided by experts is general only and should not be used for diagnosing or treating a health problem or a disease, or relied upon as legal or other professional advice. This information is not a substitute for professional advice or care.

powered by ExpertViewpoint